(Q81544568)

English

Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA

scientific article published on 15 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mycobacterium bovis

object named as

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Philip J Hogarth

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Karen E Logan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jose Candido Ferraz

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R Glyn Hewinson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

15 November 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

95-101

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

The role of CpG in DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Protection against tuberculosis by a plasmid DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

The complete genome sequence of Mycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

A selective oleic acid albumin agar medium for the cultivation ofMycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.115

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.07.115

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16314009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81544568&oldid=1779665169"